Medication Adherence in Patients With Sarcoidosis (NCT05438095)
Medication Adherence and Clinical Outcomes in Sarcoidosis
🩺 Plain-English Summary (8th-Grade Level)
The goal of the study is to look at the relationship between how individuals with Sarcoidosis take the sarcoidosis medicines and how it affects the disease, to evaluate any factors that may make individuals not want to take the medicines, and to develop and refine ways to help support individuals with Sarcoidosis especially when it comes to the medicines. The overall hypothesis is higher medication adherence will be associated with better clinical outcomes in sarcoidosis. The investigators will enroll 150 patients with biopsy proven pulmonary sarcoidosis for at least one year who are on any oral treatment regimen for at least six months into a 12-month longitudinal study.
Who can join: Review the eligibility criteria below.
Location: Johns Hopkins Bayview Asthma and Allergy Center — Baltimore, Maryland
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Johns Hopkins Bayview Asthma and Allergy Center — Baltimore, Maryland
- Johns Hopkins Greenspring Station — Timonium, Maryland
📞 Contact the Study Coordinator
Phone: (855) 694-6725
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Medication Adherence
- My Interprofessional Care Team for Adherence and Research Engagement Disparities — Springfield, Massachusetts
- MITIGAAT: Multifaceted Intervention To Improve Graft Outcome Disparities in African American Kidney Transplants — Charleston, South Carolina
- Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda — Boston, Massachusetts
- Adaptive Cell Phone Support (ACPS) — Los Angeles, California
- A Mobile Gaming App to Improve Adherence to PrEP — Boston, Massachusetts
Explore by condition: All Medication Adherence clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.